Abstract
It is well known that inflammatory bowel disease is a high-risk group for colorectal cancer. In particular, the cumulative incidence of colorectal cancer associated with ulcerative colitis (UC) has been shown to increase to about 10% by 25 years after the initial diagnosis of UC. Furthermore, the number of patients with UC is increasing in Japan, and it is predicted that the frequency of UC-associated neoplastic lesions (UCAN) will increase in the future. In this book, we describe the endoscopic diagnosis of UCAN in Surveillance for Colorectal Endoscopic Neoplasia Detection and Management in Inflammatory Bowel Disease Patients International Consensus Statement (SCENIC) and Frankfurt Advanced Chromoendoscopic Ibd Lesions (FACILE), and discuss the problems of endoscopic diagnosis of UCAN. I would like to consider the problems of endoscopic diagnosis of UCAN.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14:931–68.
Beaugerie L, Itzkowitz SH. Cancers complicating inflammatory bowel disease. N Engl J Med. 2015;372:1441–52.
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc. 2015;81:489–501.
Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148:639–51.
Workshop PitP. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58:S3–43.
Feueustein JD, Rakowsky S, Sattler L, et al. Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer. Gastrointest Endosc. 2019;90:186–95.
Bisschops R, Bessissow T, Dekker E, et al. Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis. Gastrointest Endosc. 2017;86:1100–6.
Mohan BP, Khan SR, Chandan S, et al. Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93:59–67.
Watanabe T, Ajioka Y, Mitsuyama K, et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal. Gastroenterology. 2016;151:1122–30.
Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2017;67:616–24.
Chiu K, Riddell RH, Schaeffer DF. DALM, rest in peace: a pathologist’s perspective on dysplasia in inflammatory bowel disease in the post-DALM era. Mod Pathol. 2018;31:1180–90.
Iacucci M, McQuaid K, Gui XS, et al. Multimodal (FACILE) classification for optical diagnosis of inflammatory bowel disease associated neoplasia. Endoscopy. 2019;51:133–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Matsumoto, T. (2022). Endoscopic Diagnosis of Neoplastic Lesions in Inflammatory Bowel Disease. In: Matsui, T., Iwashita, A., Matsumoto, T., Hisabe, T., Futami, K., Tanabe, H. (eds) Atlas of Inflammatory Bowel Disease-Associated Intestinal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-19-3413-1_2
Download citation
DOI: https://doi.org/10.1007/978-981-19-3413-1_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-3412-4
Online ISBN: 978-981-19-3413-1
eBook Packages: MedicineMedicine (R0)